New Century Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
New Century Advisors's XBI Position: Q3 2022 in Review
New Century Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 18,279% in Q3 2022, buying an estimated $1.33M and bringing the position to 15,806 shares worth $1.25M. The position accounts for 1.53% of the portfolio, ranked #19.
New Century Advisors first reported a position in XBI in Q2 2022 and has held it in 2 quarters since. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.
- New Century Advisors held 15,806 shares of State Street SPDR S&P Biotech ETF worth $1.25M as of Q3 2022.
- New Century Advisors bought 15,720 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $1.33M.
- State Street SPDR S&P Biotech ETF made up 1.53% of New Century Advisors's portfolio in Q3 2022, its #19 holding.
- New Century Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 2 quarters since.
- 704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.
Based on New Century Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.